Business
AiViva Biopharma Completes Enrollment in a Phase 1 Clinical Trial of AIV007 for Age-Related Macular Degeneration and Diabetic Macular Edema
AiViva Biopharma Completes Enrollment in a Phase 1 Clinical Trial of AIV007 for Age-Related Macular Degeneration and Diabetic Macular Edema GlobeNewswire August 23, 2024 Novel JEL™ Technology for Per
![AiViva Biopharma Completes Enrollment in a Phase 1 Clinical Trial of AIV007 for Age-Related Macular Degeneration and Diabetic Macular Edema](https://phuketnews.easybranches.com/uploads/news/2024/08/aiviva-biopharma-completes-enrollment-in-a-phase-1-clinical-trial-of-aiv007-for-age-related-macular-degeneration-and-diabetic-macular-edema.jpg)
GlobeNewswire
August 23, 2024
Novel JEL™ Technology for Periocular Administration